{
    "title": "Actavis plans new merger approach for Allergan -sources",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2784146/Actavis-plans-new-merger-approach-Allergan-sources.html",
    "date": "2014-10-08",
    "keywords": [
        "allergan",
        "share",
        "valeant",
        "takeover",
        "company",
        "matter",
        "offer",
        "person",
        "cost",
        "percent",
        "cash",
        "shareholder",
        "acquisition",
        "merger",
        "october",
        "york",
        "oct",
        "inc",
        "possibility",
        "management",
        "interest",
        "ackman",
        "actavis",
        "investor",
        "stock",
        "price",
        "target",
        "dec",
        "meeting",
        "square",
        "ceo",
        "part",
        "lomb",
        "deal",
        "reporting",
        "approach",
        "gmt",
        "email",
        "damouni",
        "kimnew",
        "botox",
        "maker",
        "sale",
        "tuesdayallergan",
        "proposal",
        "combination",
        "look",
        "team",
        "week",
        "engagement",
        "overture",
        "partner",
        "plan",
        "mattervaleant",
        "bid",
        "timing",
        "amount",
        "bump",
        "revenue",
        "growth",
        "emergence",
        "suitor",
        "twist",
        "battle",
        "controversy",
        "challenge",
        "insider",
        "exchange",
        "news",
        "market",
        "capitalization",
        "value",
        "worth",
        "thomson",
        "poll",
        "pursuit",
        "capital",
        "majority",
        "companys",
        "board",
        "canadian",
        "drugmakeractavis",
        "opportunity",
        "fit",
        "pyott",
        "research",
        "development",
        "mike",
        "pearson",
        "business",
        "area",
        "bausch",
        "unlikelyvaleant",
        "independentbut",
        "opposition",
        "valeantallergan",
        "drugmaker",
        "vote",
        "valuation",
        "likelihood"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}